1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Genetic Testing Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6

3 Genetic Testing Market, Canada 7
3.1 Genetic Testing Market, Canada, Revenue ($m), 2010-2017 7
3.2 Genetic Testing Market, Canada, Revenue ($m), 2017-2024 9
3.3 Genetic Testing Market, Canada, Distribution Share by Revenue ($m), 2017 11
3.4 Genetic Testing Market, Canada, Company Share by Revenue ($m), 2017 12

4 Overview of Key Companies in Canada, Genetic Testing Market 14
4.1 F. Hoffmann-La Roche Ltd 14
4.1.1 Company Overview 14
4.2 Abbott Laboratories 14
4.2.1 Company Overview 14
4.3 PerkinElmer Inc 14
4.3.1 Company Overview 14
4.4 Myriad Genetics Inc 15
4.4.1 Company Overview 15
4.5 Hologic Inc 15
4.5.1 Company Overview 15
4.6 Fujirebio Europe NV 15
4.6.1 Company Overview 15
4.7 Qiagen NV 16
4.7.1 Company Overview 16

5 Genetic Testing Market Pipeline Products 17

6 Financial Deals Landscape 19
6.1 Debt Offerings 19
6.1.1 GeneNews Raises USD0.7 Million in Private Placement of 8% Debentures Due 2019 19
6.2 Equity Offerings 20
6.2.1 3D Signatures to Raise up to USD2 Million in Private Placement of Units 20
6.2.2 3D Signatures Raises USD0.4 Million in Private Placement of Shares 21
6.3 Partnerships 22
6.3.1 Lucigen Enters into Distribution Agreement with Illumina 22
6.4 Venture Financing 23
6.4.1 GeneNews Raises USD0.2 Million in Venture Financing 23

7 Recent Developments 24
7.1 Corporate Communications 24
7.1.1 Oct 19, 2017: 3D Signatures Announces Changes to Its Board of Directors 24
7.1.2 Oct 10, 2017: 3D Signatures Announces Change to Its Board of Directors 24
7.1.3 Aug 11, 2017: 3D Signatures Announces Change to its Board of Directors 24
7.1.4 Jun 30, 2017: GeneNews Announces Election of Directors 24
7.1.5 May 05, 2017: 3D Signatures Announces Change to Its Board of Directors 24
7.1.6 Apr 11, 2017: 3D Signatures Announces Appointment of Dr. Kevin Little as Chief Scientific Officer 24
7.1.7 Feb 15, 2017: 3D Signatures Adds Medical Diagnostic Expert to Business Advisory Board 25
7.1.8 Jan 06, 2017: 3D Signatures Appoints Accomplished Healthcare Veteran as Chief Business Officer 26
7.1.9 Dec 09, 2016: 3D Signatures announces board changes 26
7.1.10 Dec 05, 2016: 3D Signatures appoints new member to 3DS’ business advisory board 27
7.1.11 Nov 29, 2016: ARxIUM Introduces New RIVA Automated IV Compounding System 28
7.1.12 Nov 28, 2016: World Lung Conference Features Data Demonstrating Clinical Utility and Cost Effectiveness of Trovagene’s Liquid Biopsy Tests for Mutation Detection and Monitoring in NSCLC Patients 28
7.1.13 Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 29
7.1.14 Nov 28, 2016: Konica Minolta Healthcare Introduces New Digital U-Arm Featuring Cutting-Edge Technology at RSNA 2016 31
7.1.15 Nov 28, 2016: MEDICREA Achieves Personalized Spine Milestone with 1,000 Patient-Specific UNiD Rod Procedures 31
7.1.16 Nov 28, 2016: Corsens Medical Announces Clearance of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor 32
7.1.17 Nov 14, 2016: 3D Signatures Introduces Internationally Recognized Clinical and Scientific Advisory Board 32
7.1.18 Oct 27, 2016: 3D Signatures Introduces Business Advisory Board and Celebrates Recent Listing by Opening Toronto Stock Exchange November 2 34
7.2 Financial Announcements 35
7.2.1 Oct 24, 2017: 3D Signatures Reports Financial Results for 2017 35
7.2.2 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 36
7.2.3 May 31, 2017: 3D Signatures Reports Third Quarter 2017 Financial Results 37
7.2.4 May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update 38
7.2.5 Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results 39
7.2.6 Mar 02, 2017: 3D Signatures Reports Second Quarter 2017 Financial Results 40
7.2.7 Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update 41
7.3 Legal And Regulatory 42
7.3.1 Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 42
7.3.2 Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 42
7.4 Product News 42
7.4.1 Mar 14, 2017: 3D Signatures Makes Final Patent Payment 42

8 Appendix 44
8.1 Research Methodology 45
8.1.1 Coverage 45
8.1.2 Secondary Research 45
8.1.3 Primary Research 46
8.1.4 Market Modeling and Forecasting 47
8.1.5 Company Share Analysis 48
8.1.6 Distribution Share Analysis 49
8.1.7 Benchmarking 49
8.2 GlobalData Consulting 49
8.3 Contact Us 50
8.4 Disclaimer 50

1.1 List of Tables
Table 1: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 8
Table 2: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 10
Table 3: Genetic Testing Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 11
Table 4: Genetic Testing Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 13
Table 5: Genetic Testing Market Pipeline Products 17
Table 6: GeneNews Raises USD0.7 Million in Private Placement of 8% Debentures Due 2019 19
Table 7: 3D Signatures to Raise up to USD2 Million in Private Placement of Units 20
Table 8: 3D Signatures Raises USD0.4 Million in Private Placement of Shares 21
Table 9: Lucigen Enters into Distribution Agreement with Illumina 22
Table 10: GeneNews Raises USD0.2 Million in Venture Financing 23
Table 11: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 47

1.2 List of Figures
Figure 1: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 7
Figure 2: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 9
Figure 3: Genetic Testing Market, Canada, Company Share (%) 2017 12

Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- PerkinElmer Inc
- Myriad Genetics Inc
- Hologic Inc
- Fujirebio Europe NV
- Qiagen NV